WO2003008590A1 - Gpat mitochondrien humain - Google Patents

Gpat mitochondrien humain Download PDF

Info

Publication number
WO2003008590A1
WO2003008590A1 PCT/JP2002/007189 JP0207189W WO03008590A1 WO 2003008590 A1 WO2003008590 A1 WO 2003008590A1 JP 0207189 W JP0207189 W JP 0207189W WO 03008590 A1 WO03008590 A1 WO 03008590A1
Authority
WO
WIPO (PCT)
Prior art keywords
human mitochondrial
mitochondrial gpat
protein
antagonist
screening
Prior art date
Application number
PCT/JP2002/007189
Other languages
English (en)
Japanese (ja)
Inventor
Sakae Sakamoto
Hideki Onota
Sumio Sugano
Yusuke Nakamura
Original Assignee
Kissei Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kissei Pharmaceutical Co., Ltd. filed Critical Kissei Pharmaceutical Co., Ltd.
Publication of WO2003008590A1 publication Critical patent/WO2003008590A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne une protéine ayant une activité de sn-glycérol-3-phosphate acyltransférase (GPAM) mitochondrienne humaine; et un procédé de criblage d'un antagoniste à l'aide de cette protéine. L'antagoniste de la protéine précitée obtenu par le procédé de criblage sert de remède lors de complications diabétiques.
PCT/JP2002/007189 2001-07-16 2002-07-16 Gpat mitochondrien humain WO2003008590A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-215337 2001-07-16
JP2001215337 2001-07-16

Publications (1)

Publication Number Publication Date
WO2003008590A1 true WO2003008590A1 (fr) 2003-01-30

Family

ID=19049997

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/007189 WO2003008590A1 (fr) 2001-07-16 2002-07-16 Gpat mitochondrien humain

Country Status (1)

Country Link
WO (1) WO2003008590A1 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057188A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002016592A2 (fr) * 2000-08-21 2002-02-28 Millennium Pharmaceuticals, Inc. Nouvelle acyltransferase humaine atcr-1 et ses utilisations
WO2002026950A2 (fr) * 2000-09-29 2002-04-04 Incyte Genomics, Inc. Transferases

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057188A2 (fr) * 2000-02-03 2001-08-09 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
WO2002016592A2 (fr) * 2000-08-21 2002-02-28 Millennium Pharmaceuticals, Inc. Nouvelle acyltransferase humaine atcr-1 et ses utilisations
WO2002026950A2 (fr) * 2000-09-29 2002-04-04 Incyte Genomics, Inc. Transferases

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BHAT B. GANESH ET AL.: "Rat sn-glycerol-3-phosphate acyltransferase: molecular cloning and characterization of the cDNA and expressed protein", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1439, 1999, pages 415 - 423, XP002957627 *
DONG-HOON SHIN ET AL.: "Transcriptional regulation of p90 with sequence homology to escherichia coli glycerol-3-phosphate acyltransferase", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 265, no. 35, 1991, pages 23834 - 23839, XP001095625 *
HEI SOOK SUL ET AL.: "Nutritional and hormonal regulation of enzymes in fat synthesis: Studies of fatty acid synthase and mitochondrial glycerol-3-phosphate acyltransferase gene transcription", ANNU. REV. NUTR., vol. 18, 1998, pages 331 - 351, XP002957629 *
SHAW-FANG YET ET AL.: "Purification and reconstitution of murine mitochondrial glycerol-3-phosphate acyltransferase. Functional expression in baculovirus-infected insect cells", BIOCHEMISTRY, vol. 34, 1995, pages 7303 - 7310, XP002957628 *
TAKAHIRO NAGASE ET AL.: "Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins", DNA RESEARCH, vol. 7, 2000, pages 273 - 281, XP001012454 *

Similar Documents

Publication Publication Date Title
AU2003302885A1 (en) Disposable diaper producing method
AU2003287735A1 (en) Non-invasive measurement of analytes
AU2002346486A1 (en) Method for adjusting a blood analyte measurement
AU2002356861A1 (en) Fibrin membrane and methods for its preparation- application to artificial skin
AU2003229629A1 (en) A process for the preparation of stem cells from human muscle tissue and adipose tissue, and stem cells obtainable by this process
EP1283235A3 (fr) Composition, méthode de fabrication et méthode d'utilisation de la composition adhésive
AU2003255035A1 (en) Method for testing precursor of secondary cell, its testing instrument, and method for manufacturing secondary cell using the method
AU2002332164A1 (en) Method of producing disposable diaper
AU2003300324A1 (en) Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
AU2003272976A1 (en) Disposable diaper
AU2003293589A1 (en) Heavy ceramic moulded body, method for producing said body and use of the same
WO2002033089A3 (fr) Inhibiteur de la voie de facteur tissulaire d'ixodes scapularis
WO2003008590A1 (fr) Gpat mitochondrien humain
EP1573036A3 (fr) Sondes d'adn subtelomeriques et leur procede de production
WO2003091447A3 (fr) Acides nucleiques d1-1, polypeptides et methodes associees
AU2002346275A1 (en) An orientation coating method of the top of micro tip.
AU2002328285A1 (en) Method for producing an essentially chlorite-free, stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
AU2002364599A1 (en) Suture trimmer
AU2002348722A1 (en) Methods and reagents for the control of infestations of parasites
EP1260810A3 (fr) Méthode pour calibrer un analyseur d'échantillons
WO2004020463A3 (fr) Proteine mutante et procede de repliement
AU2002950183A0 (en) Expression of hydrophobic proteins
EP1801966A3 (fr) Détermination d'un niveau de puissance entre intervalles de temps
WO2004065224A3 (fr) Dispositif de fixation
AU2003267356A1 (en) Proteins having polysaccharidase activity

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP